In Vivo Evaluation of Indium-111–Labeled 800CW as a Necrosis-Avid Contrast Agent

PURPOSE: Current clinical measurements for tumor treatment efficiency rely often on changes in tumor volume measured as shrinkage by CT or MRI, which become apparent after multiple lines of treatment and pose a physical and psychological burden on the patient. Detection of therapy-induced cell death...

Descripción completa

Detalles Bibliográficos
Autores principales: Stroet, Marcus C. M., de Blois, Erik, Stuurman, Debra C., de Ridder, Corrina M. A., Haeck, Joost, Seimbille, Yann, Mezzanotte, Laura, de Jong, Marion, Löwik, Clemens W. G. M., Panth, Kranthi M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497446/
https://www.ncbi.nlm.nih.gov/pubmed/32514888
http://dx.doi.org/10.1007/s11307-020-01511-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497446/
https://www.ncbi.nlm.nih.gov/pubmed/32514888
http://dx.doi.org/10.1007/s11307-020-01511-x

Ejemplares similares